(19)
(11) EP 4 064 964 A1

(12)

(43) Date of publication:
05.10.2022 Bulletin 2022/40

(21) Application number: 20819830.9

(22) Date of filing: 25.11.2020
(51) International Patent Classification (IPC): 
A61B 5/00(2006.01)
G06K 9/00(2022.01)
G06F 3/0354(2013.01)
G16H 50/30(2018.01)
(52) Cooperative Patent Classification (CPC):
G16H 50/30; G06F 3/03545; A61B 5/4082; A61B 2505/09; A61B 5/1124; A61B 5/4088; A61B 5/7275; A61B 5/7495; A61B 5/742; G16H 20/70; G16H 40/63; G16H 50/20
(86) International application number:
PCT/GB2020/052995
(87) International publication number:
WO 2021/105667 (03.06.2021 Gazette 2021/22)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.11.2019 GB 201917146

(71) Applicant: Huma Therapeutics Limited
London SW1P 4QP (GB)

(72) Inventors:
  • STRAUSS, Tamir
    London Greater London SW1P 4QP (GB)
  • BINNING, Emily
    London Greater London SW1P 4QP (GB)
  • VAHDAT, Danoosh
    London Greater London SW1P 4QP (GB)
  • HUDDLESTONE, Robert
    London Greater London SW1P 4QP (GB)

(74) Representative: Matter IP Limited 
27 Old Gloucester Street
London WC1N 3AX
London WC1N 3AX (GB)

   


(54) NEURODEGENERATION MONITORING